APA (7th ed.) Citation

M, L., MM, P., A, A., D, K., T, G., E, C., . . . BR, H. (2026). Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab: A Global Population-Based Study across 65 Countries. Ophthalmology. Retina, 10(4), 373. https://doi.org/10.1016/j.oret.2025.10.019

Chicago Style (17th ed.) Citation

M, Lakhani, et al. "Comparative Analysis of Ocular Adverse Events Between Aflibercept 8 Mg and Faricimab: A Global Population-Based Study Across 65 Countries." Ophthalmology. Retina 10, no. 4 (2026): 373. https://doi.org/10.1016/j.oret.2025.10.019.

MLA (9th ed.) Citation

M, Lakhani, et al. "Comparative Analysis of Ocular Adverse Events Between Aflibercept 8 Mg and Faricimab: A Global Population-Based Study Across 65 Countries." Ophthalmology. Retina, vol. 10, no. 4, 2026, p. 373, https://doi.org/10.1016/j.oret.2025.10.019.